Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (301-310 of 357) with videos related to

Pageof 36
Sort By:
The Journal of Pathology|October 1, 2008
Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survivalJ M W Gee, J J Eloranta, J C Ibbitt, et al.
Journal of the National Cancer Institute|May 17, 1995
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancerC K Osborne, E B Coronado-Heinsohn, S G Hilsenbeck, et al.
International Journal of Cancer|October 23, 2001
TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independenceE Glynne-Jones, M E Harper, L T Seery, et al.
Oncogene|October 27, 1998
c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancerJ M Knowlden, J M Gee, L T Seery, et al.
Anticancer Research|March 1, 1996
The significance of p53 autoantibodies in the serum of patients with breast cancerP C Willsher, S E Pinder, L Robertson, et al.
Histopathology|September 13, 2011
A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancerHany O Habashy, Desmond G Powe, Tarek M Abdel-Fatah, et al.
Cancer Research|January 15, 1994
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancerD J DeFriend, A Howell, R I Nicholson, et al.
Endocrinology|February 15, 2003
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cellsJanice M Knowlden, Iain R Hutcheson, Helen E Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivityR I Nicholson, R A McClelland, P Finlay, et al.
The Journal of Pathology|May 14, 2004
Expression of luminal and basal cytokeratins in human breast carcinomaDalia M Abd El-Rehim, Sarah E Pinder, Claire E Paish, et al.
Pageof 36

Showing results (301-310 of 357) with videos related to

Sort By:
Pageof 36
The Journal of Pathology|October 1, 2008
Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survivalJ M W Gee, J J Eloranta, J C Ibbitt, et al.
Journal of the National Cancer Institute|May 17, 1995
Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancerC K Osborne, E B Coronado-Heinsohn, S G Hilsenbeck, et al.
International Journal of Cancer|October 23, 2001
TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independenceE Glynne-Jones, M E Harper, L T Seery, et al.
Oncogene|October 27, 1998
c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancerJ M Knowlden, J M Gee, L T Seery, et al.
Anticancer Research|March 1, 1996
The significance of p53 autoantibodies in the serum of patients with breast cancerP C Willsher, S E Pinder, L Robertson, et al.
Histopathology|September 13, 2011
A review of the biological and clinical characteristics of luminal-like oestrogen receptor-positive breast cancerHany O Habashy, Desmond G Powe, Tarek M Abdel-Fatah, et al.
Cancer Research|January 15, 1994
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancerD J DeFriend, A Howell, R I Nicholson, et al.
Endocrinology|February 15, 2003
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cellsJanice M Knowlden, Iain R Hutcheson, Helen E Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivityR I Nicholson, R A McClelland, P Finlay, et al.
The Journal of Pathology|May 14, 2004
Expression of luminal and basal cytokeratins in human breast carcinomaDalia M Abd El-Rehim, Sarah E Pinder, Claire E Paish, et al.
Pageof 36